173 related articles for article (PubMed ID: 26918893)
1. Clinical translation of ferumoxytol-based vessel size imaging (VSI): Feasibility in a phase I oncology clinical trial population.
Fredrickson J; Serkova NJ; Wyatt SK; Carano RA; Pirzkall A; Rhee I; Rosen LS; Bessudo A; Weekes C; de Crespigny A
Magn Reson Med; 2017 Feb; 77(2):814-825. PubMed ID: 26918893
[TBL] [Abstract][Full Text] [Related]
2. Comparison of ferumoxytol-based cerebral blood volume estimates using quantitative R
Rivera-Rivera LA; Schubert T; Knobloch G; Turski PA; Wieben O; Reeder SB; Johnson KM
Magn Reson Med; 2018 Jun; 79(6):3072-3081. PubMed ID: 29096054
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric characterization of response to anti-angiogenic therapy using USPIO contrast-enhanced MRI in combination with dynamic contrast-enhanced MRI.
Kim J; Kim E; Euceda LR; Meyer DE; Langseth K; Bathen TF; Moestue SA; Huuse EM
J Magn Reson Imaging; 2018 Jun; 47(6):1589-1600. PubMed ID: 29205621
[TBL] [Abstract][Full Text] [Related]
4. Ferumoxytol Does Not Impact Standardized Uptake Values on PET/MR Scans.
Muehe AM; Yerneni K; Theruvath AJ; Thakor AS; Pribnow A; Avedian R; Steffner R; Rosenberg J; Hawk KE; Daldrup-Link HE
Mol Imaging Biol; 2020 Jun; 22(3):722-729. PubMed ID: 31325083
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of benign and malignant lymph nodes in pediatric patients on ferumoxytol-enhanced PET/MRI.
Muehe AM; Siedek F; Theruvath AJ; Seekins J; Spunt SL; Pribnow A; Hazard FK; Liang T; Daldrup-Link H
Theranostics; 2020; 10(8):3612-3621. PubMed ID: 32206111
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of ultrasmall superparamagnetic iron-oxide (USPIO) enhanced MRI with ferumoxytol to quantify arterial wall inflammation.
Smits LP; Tiessens F; Zheng KH; Stroes ES; Nederveen AJ; Coolen BF
Atherosclerosis; 2017 Aug; 263():211-218. PubMed ID: 28662398
[TBL] [Abstract][Full Text] [Related]
7. Quantitative comparison of delayed ferumoxytol T
Horváth A; Varallyay CG; Schwartz D; Toth GB; Netto JP; Barajas R; Várallyay P; Szidonya L; Firkins J; Youngers E; Fu R; Ambady P; Bogner P; Neuwelt EA
Magn Reson Med; 2018 Jul; 80(1):224-230. PubMed ID: 29205477
[TBL] [Abstract][Full Text] [Related]
8. Macrophage Imaging of Cerebral Aneurysms with Ferumoxytol: an Exploratory Study in an Animal Model and in Patients.
Aoki T; Saito M; Koseki H; Tsuji K; Tsuji A; Murata K; Kasuya H; Morita A; Narumiya S; Nozaki K;
J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2055-2064. PubMed ID: 28774792
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice.
Persigehl T; Bieker R; Matuszewski L; Wall A; Kessler T; Kooijman H; Meier N; Ebert W; Berdel WE; Heindel W; Mesters RM; Bremer C
Radiology; 2007 Aug; 244(2):449-56. PubMed ID: 17562810
[TBL] [Abstract][Full Text] [Related]
10. Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI.
Beaumont M; Lemasson B; Farion R; Segebarth C; Rémy C; Barbier EL
J Cereb Blood Flow Metab; 2009 Oct; 29(10):1714-26. PubMed ID: 19584891
[TBL] [Abstract][Full Text] [Related]
11. Cerebral blood volume mapping with ferumoxytol in dynamic susceptibility contrast perfusion MRI: Comparison to standard of care.
Varallyay CG; Nesbit E; Horvath A; Varallyay P; Fu R; Gahramanov S; Muldoon LL; Li X; Rooney WD; Neuwelt EA
J Magn Reson Imaging; 2018 Aug; 48(2):441-448. PubMed ID: 29314418
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of magnetic resonance vessel size imaging by two-photon laser scanning microscopy.
Douma K; Oostendorp M; Slaaf DW; Post MJ; Backes WH; van Zandvoort MA
Magn Reson Med; 2010 Apr; 63(4):930-9. PubMed ID: 20373394
[TBL] [Abstract][Full Text] [Related]
13. Prediction of antiangiogenic treatment efficacy by iron oxide enhanced parametric magnetic resonance imaging.
Persigehl T; Matuszewski L; Kessler T; Wall A; Meier N; Ebert W; Berdel WE; Heindel W; Mesters R; Bremer C
Invest Radiol; 2007 Dec; 42(12):791-6. PubMed ID: 18007150
[TBL] [Abstract][Full Text] [Related]
14. Cerebral blood volume estimation by ferumoxytol-enhanced steady-state MRI at 9.4 T reveals microvascular impact of α1 -adrenergic receptor antibodies.
Pohlmann A; Karczewski P; Ku MC; Dieringer B; Waiczies H; Wisbrun N; Kox S; Palatnik I; Reimann HM; Eichhorn C; Waiczies S; Hempel P; Lemke B; Niendorf T; Bimmler M
NMR Biomed; 2014 Sep; 27(9):1085-93. PubMed ID: 25060359
[TBL] [Abstract][Full Text] [Related]
15. Vessel size imaging (VSI) by robust magnetic resonance (MR) relaxometry: MR-VSI of solid tumors in correlation with immunohistology and intravital microscopy.
Persigehl T; Ring J; Budny T; Hahnenkamp A; Stoeppeler S; Schwartz LH; Spiegel HU; Heindel W; Remmele S; Bremer C
Mol Imaging; 2013 Oct; 12(7):1-11. PubMed ID: 23962676
[TBL] [Abstract][Full Text] [Related]
16. Vessel size imaging using dual contrast agent injections.
Hsu YY; Yang WS; Lim KE; Liu HL
J Magn Reson Imaging; 2009 Nov; 30(5):1078-84. PubMed ID: 19856441
[TBL] [Abstract][Full Text] [Related]
17. Improved perfusion MR imaging assessment of intracerebral tumor blood volume and antiangiogenic therapy efficacy in a rat model with ferumoxytol.
Gahramanov S; Muldoon LL; Li X; Neuwelt EA
Radiology; 2011 Dec; 261(3):796-804. PubMed ID: 21940504
[TBL] [Abstract][Full Text] [Related]
18. Distinguishing Extravascular from Intravascular Ferumoxytol Pools within the Brain: Proof of Concept in Patients with Treated Glioblastoma.
Barajas RF; Schwartz D; McConnell HL; Kersch CN; Li X; Hamilton BE; Starkey J; Pettersson DR; Nickerson JP; Pollock JM; Fu RF; Horvath A; Szidonya L; Varallyay CG; Jaboin JJ; Raslan AM; Dogan A; Cetas JS; Ciporen J; Han SJ; Ambady P; Muldoon LL; Woltjer R; Rooney WD; Neuwelt EA
AJNR Am J Neuroradiol; 2020 Jul; 41(7):1193-1200. PubMed ID: 32527840
[TBL] [Abstract][Full Text] [Related]
19. Vessel size index measurements in a rat model of glioma: comparison of the dynamic (Gd) and steady-state (iron-oxide) susceptibility contrast MRI approaches.
Pannetier N; Lemasson B; Christen T; Tachrount M; Troprès I; Farion R; Segebarth C; Rémy C; Barbier EL
NMR Biomed; 2012 Feb; 25(2):218-26. PubMed ID: 21751270
[TBL] [Abstract][Full Text] [Related]
20. Imaging Tumor Necrosis with Ferumoxytol.
Aghighi M; Golovko D; Ansari C; Marina NM; Pisani L; Kurlander L; Klenk C; Bhaumik S; Wendland M; Daldrup-Link HE
PLoS One; 2015; 10(11):e0142665. PubMed ID: 26569397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
